Maintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhood.

Maintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhood.

The objectives of this study were to evaluate the kinetics of antibody decline through childhood in a longitudinal study of a single cohort following serogroup C meningococcal (MenC) vaccine immunization in early childhood and to calculate the proportion of 11 to 13 year olds with protective levels...

Full description

Bibliographic Details
Main Authors:	Khatami, A, Peters, A, Robinson, H, Williams, N, Thompson, A, Findlow, H, Pollard, A, Snape, MD
Format:	Journal article
Language:	English
Published:	2011

Similar Items

No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales - Authors' reply
by: Snape, MD, et al.
Published: (2006)

Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.
by: Maiden, M, et al.
Published: (2008)

Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines - exploratory analyses within a randomised controlled trial
by: Khatami, A, et al.
Published: (2014)

Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial.
by: Khatami, A, et al.
Published: (2011)

B cell memory to a serogroup C meningococcal conjugate vaccine in childhood and response to booster: little association with serum IgG antibody.
by: Perrett, K, et al.
Published: (2012)

Meningococcal polysaccharide-protein conjugate vaccines.
by: Snape, MD, et al.
Published: (2005)

Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.
by: Pace, D, et al.
Published: (2015)

Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccine
by: O'Connor, D, et al.
Published: (2014)

Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccine.
by: O'Connor, D, et al.
Published: (2014)

Serogroup B meningococcal vaccines-an unfinished story.
by: Sadarangani, M, et al.
Published: (2010)

Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.
by: Kelly, D, et al.
Published: (2009)

Common Genetic Variations Associated with the Persistence of Immunity following Childhood Immunization
by: O'Connor, D, et al.
Published: (2019)

Will booster doses be required for serogroup B meningococcal vaccine?
by: McQuaid, F, et al.
Published: (2014)

Single nucleotide polymorphisms in the Toll-like receptor 3 and CD44 genes are associated with persistence of vaccine-induced immunity to the serogroup C meningococcal conjugate vaccine.
by: Moore, C, et al.
Published: (2012)

Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine.
by: Snape, MD, et al.
Published: (2009)

Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination.
by: de Whalley, P, et al.
Published: (2013)

Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination
by: De Whalley, P, et al.
Published: (2013)

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: A community study
by: Daugla, D, et al.
Published: (2013)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose.
by: Snape, MD, et al.
Published: (2013)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
by: Snape, M, et al.
Published: (2013)

Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine
by: Blanchard-Rohner, G, et al.
Published: (2012)

Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine.
by: Blanchard-Rohner, G, et al.
Published: (2012)

Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial.
by: Snape, MD, et al.
Published: (2010)

Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine.
by: Snape, MD, et al.
Published: (2005)

Single nucleotide polymorphisms in the toll-like receptor 3 and CD44 genes are associated with persistence of vaccine-induced immunity to the serogroup C meningococcal conjugate vaccine
by: Moore, C, et al.
Published: (2012)

The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012.
by: Sadarangani, M, et al.
Published: (2014)

Meningococcal polysaccharide-protein conjugate vaccines (vol 5, pg 21, 2005)
by: Snape, MD, et al.
Published: (2005)

Challenges and progress in the development of a serogroup B meningococcal vaccine.
by: Lewis, S, et al.
Published: (2009)

CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells.
by: Kelly, D, et al.
Published: (2006)

Plasma and memory B-cell kinetics in infants following a primary schedule of CRM197-conjugated serogroup C meningococcal polysaccharide vaccine (vol 127, pg 134, 2009)
by: Kelly, D, et al.
Published: (2011)

Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135.
by: Keyserling, H, et al.
Published: (2006)

Persistence of bactericidal antibodies to 5 years of age after immunization with serogroup B meningococcal vaccines at 6, 8, 12 and 40 months of age.
by: McQuaid, F, et al.
Published: (2014)

Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease.
by: Pollard, A, et al.
Published: (2013)

Persistence of bactericidal antibodies following infant serogroup B meningococcal immunization (4CMenB) and booster dose response at 12, 18 or 24 months of age
by: Snape, M, et al.
Published: (2015)

The epidemiology of meningococcal disease and the impact of vaccines.
by: Khatami, A, et al.
Published: (2010)

Quadrivalent meningococcal conjugate vaccines
by: Pace, D, et al.
Published: (2009)

Quadrivalent meningococcal conjugate vaccines.
by: Pace, D, et al.
Published: (2009)

The Cost of Preterm Birth Throughout Childhood in England and Wales
by: Mangham, L, et al.
Published: (2009)

Changes in epigenetic profiles throughout early childhood and their relationship to the response to pneumococcal vaccination
by: Pischedda, S, et al.
Published: (2021)

Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
by: Xie, O, et al.
Published: (2013)